PRIP Approves INR 1,600 Crore for 41 Pharma and MedTech Projects
The PRIP first round has approved INR 1,600 crore for 41 pharma and medtech innovation projects, spanning novel drug discovery and advanced medical technologies.
Complex Generics | 01/10/2026 | By News Bureau
Granules India secures Sole First-to-File ANDA status for Sodium Oxybate Extended-Release for Oral Suspension, strengthening its US complex generics portfolio.
Complex Generics | 06/07/2026 | By Akanki | 234
Amneal Unveils New Brand to Expand Access to Medicines
The refreshed brand features a new visual identity and “Signature” logo that reflects trust in healthcare, patient impact, and Amneal’s focus on expanding access to medicines across complex therapeutic areas.
Complex Generics | 15/01/2026 | By News Bureau | 322
ScinoPharm Wins FDA Approval for Glatiramer Acetate Injection
ScinoPharm Taiwan has received US FDA approval for its Glatiramer Acetate Injection for the treatment of multiple sclerosis, marking a significant milestone as the first and only Taiwanese pharmaceutical company to secure FDA approval for this complex generic, and reinforcing Taiwan’s growing role in the global pharmaceutical supply chain.
Complex Generics | 05/01/2026 | By News Bureau | 233
Lupin Expands US Footprint with New Corporate Offices in Bridgewater, New Jersey
Lupin has inaugurated its new corporate offices at 100 Somerset Corporate Blvd, Bridgewater, New Jersey, expanding its presence in the state where it already operates manufacturing and research facilities.
Complex Generics | 28/10/2025 | By Dineshwori | 387
Senores Pharmaceuticals Appoints Manohar Lalge as President - Research & Development
Senores Pharmaceuticals Ltd. (SPL) has appointed Manohar Lalge as President – Research and Development.
Complex Generics | 20/08/2025 | By Dineshwori | 617
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy